Advance Biosensors for Point-of-Care
Deadline for manuscript submissions: closed (20 September 2021) | Viewed by 16557
Interests: molecular; diagnostics; point-of-care; microarrays; Infection; biomarkers; cancer diagnostics; virology; molecular biology; biochemistry; analytical chemistry; bioanalysis; medical diagnostics; precision medicine
Special Issues, Collections and Topics in MDPI journals
Biosensors are analytical devices that allow the detection or monitoring of specific biomarkers by converting their biological response into electrical or measurable signals. Monitoring specific biomarkers such as nucleic acids, enzymes, antibodies, proteins, macro/micromolecules and metabolites can provide information about metabolic disorders, disease state or changes to environmental conditions. Biosensors are an integral part of point-of-care (POC) test devices, a class of in vitro diagnostic tests that are conducted outside central testing laboratories—for example, tests conducted in doctor’s offices, pharmacies, field, patient homes, care homes, small clinics or at near patient testing sites. POC tests also extend to wearable and home/self-testing devices. POC requires non-specialized training and can be performed in a timely manner in order to make rapid and accurate clinical/patient management decisions.
The increasing number of more complex diseases, antibiotic-resistant pathogens as well as the recent outbreak of COVID-19 infection worldwide have further emphasized the need for accurate, timely, and robust point-of-care diagnostic tests. The use of POC tests will continue to grow rapidly due to the need for personalized treatment and decentralized testing, representing a paradigm-shift in global healthcare. Consequently, advances in Biosensors technologies will be a key enabler of Point-of-Care diagnostic tests. Advances in biosensor research and development in areas such as (but not limited to) electrochemical detection, electromagnetic, optical/visual, immnunosensors, lab-chip, nanotechnology to bioelectronics, fluorescence detection, and nucleic acid biosensors will enable more robust and cost-effective POC tests. In this Special Issue, we welcome all research and development that advance biosensors technologies and their application in point-of-care and self-testing.
Dr. Kevin Eboigbodin
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Home testing
- Field testing
- Fluorescence detection
- Nucleic acid detection
- Machine learning
- Smart phones